510(k) Report

510(k) · Cleared

Cleared

LineUp

K180727510(k) TraditionalCleared May 11, 201852-day reviewClass II21 CFR 892.1750

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Curvebeam, LLC · JAK System, X-Ray, Tomography, Computed

Cleared on May 11, 2018 as substantially equivalent to K113548 (Curvebeam, LLC, 2012) after a 52-day review. Its family tree reaches back 1 generation to 2012. 2 later devices descend from it.

Decided
May 11, 2018
Review
52 days
Class
Class II
Product code
JAK
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K113548 (2012). 2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2020: 1 descendant cleared2024: 1 descendant clearedReference device: K160857 · HF 718BD X-Ray System · Arquilla, Inc. Dba X-Cel X-Ray Corporation · 2017K113548 · Pedcat · Curvebeam, LLC · 20122010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant K113548 · Pedcat · Curvebeam, LLC · 20120
  1. Root · 1 generation backK113548 PedcatCurvebeam, LLC · 2012
  2. This deviceK180727 LineUpCurvebeam, LLC · 2018
  3. Descendant · cites it directly · 1 of its ownK203187 HiRiseCurvebeam, LLC · 2020
  4. Descendant · 2 generations on · 0 of its ownK241713 HiRise (1040-230)Curvebeam, LLC · 2024

Most influential descendants

Showing 2 of 2 · See all
  • K203187HiRiseCurvebeam, LLC · 2020 · cites it directly1descendant
  • K241713HiRise (1040-230)Curvebeam, LLC · 2024 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K113548PedcatCurvebeam, LLC2012—
0 (this device)K180727LineUpCurvebeam, LLC2018—
+1K203187HiRiseCurvebeam, LLC2020—
+2K241713HiRise (1040-230)Curvebeam, LLC2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
202410
FIG. 1 — Lineage of K180727, 2012–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAK device

  1. #1 K230223 iCAC Devicescore 23.5 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K113548Pedcat
Summary page 5
…mber Device Code Classification CurveBeam, PedCat JAK K113548 892.1750 Class II LLC Indications for Use: The LineUP is intended to be used for 3-D imaging of the…
Curvebeam, LLC2012—
†K160857HF 718BD X-Ray SystemArquilla, Inc. Dba X-Cel X-Ray Corporation2017—

Also cleared against K113548: 1 other device →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K203187HiRiseCurvebeam, LLC20201

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K203187 (Curvebeam, LLC, 2020) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate K113548.

How does its category compare?

All JAK devices

JAK System, X-Ray, Tomography, Computed: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · JAK

27in 2025

2007: 142008: 262009: 152010: 72011: 162012: 282013: 172014: 302015: 302016: 252017: 292018: 242019: 282020: 302021: 202022: 302023: 272024: 262025: 272026 (partial year): 21
2007high 30 (2014) · low 7 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAK

141in 2025

2007: 27 days median2008: 42 days median2009: 31 days median2010: 92 days median2011: 155 days median2012: 121 days median2013: 132 days median2014: 200 days median2015: 140 days median2016: 129 days median2017: 96 days median2018: 114 days median2019: 94 days median2020: 112 days median2021: 145 days median2022: 131 days median2023: 139 days median2024: 141 days median2025: 141 days median2026 (partial year): 167 days median
2007high 200 (2014) · low 27 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAK

17in 2025

2007: 112008: 162009: 292010: 512011: 342012: 232013: 112014: 102015: 282016: 442017: 332018: 102019: 52020: 82021: 152022: 92023: 92024: 202025: 172026 (partial year): 23
2007high 51 (2010) · low 5 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAK

219in 2025

2007: 762008: 1202009: 1052010: 1192011: 2052012: 1922013: 4142014: 3082015: 4542016: 3652017: 3382018: 5432019: 2332020: 1772021: 2612022: 1992023: 3102024: 2122025: 219
2007high 543 (2018) · low 76 (2007)2025

MAUDE reports naming product code JAK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200714271176
2008264216120
2009153129105
201079251119
20111615534205
20122812123192
20131713211414
20143020010308
20153014028454
20162512944365
2017299633338
20182411410543
201928945233
2020301128177
20212014515261
2022301319199
2023271399310
20242614120212
20252714117219
20262116723—

What is it indicated for?

The LineUP is intended to be used for 3-D imaging of the foot, knee, hand, and elbow regions to visualize and assess the osseous and certain soft tissue structures, including joint spaces, bone angles and fractures.

It is also intended to capture 2-D images (standard plain x-ray projections) of the foot, knee, hand, and elbow regions.

This modality is anticipated to be applicable to pediatric* cases as well as adults, when appropriate diagnosis of a given condition is considered necessary. Patient parameters: 50 lbs to 400 lbs

*2D Imaging not intended for pediatric use

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K180727: LineUp.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K180727

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026